Sir Tom Jones opened up to fans about his recent health battle during his comeback performance at the Greek Theatre. He spent a week at the Ronald Reagan UCLA Medical Center before doctors successfully treated the severe viral infection. The singer informed medical staff that his primary objective was recovering quickly enough to resume touring and get back on stage. His upcoming performance is scheduled to take place at the Yaamava' Theater in San Bernardino, California.
Key points
Sir Tom Jones successfully returned to live performing on Wednesday with an appearance at…: Sir Tom Jones successfully returned to live performing on Wednesday with an appearance at the Greek Theatre.
The veteran vocalist emphasized to hospital staff that resuming his stage performances wa…: The veteran vocalist emphasized to hospital staff that resuming his stage performances was his ultimate priority during recovery.
Before his exit from The Voice UK, Sir Tom concluded his tenure by mentoring singer Cate…: Before his exit from The Voice UK, Sir Tom concluded his tenure by mentoring singer Cate McHugh to victory.
Sources checked by our analysis pipeline: 1
- Published
Sir Tom Jones has told fans he feared his life was "over" after being admitted to hospital in the US with flu.
The 86-year-old from Pontypridd spent a week at the Ronald Regan UCLA Medical Center in Los Angeles and was forced to cancel or reschedule a number of concerts.
But on Wednesday night, he was back on stage at the Greek Theatre and told the audience just how serious his "bad case of the flu" was.
"[I thought] Oh well, this is it, you've had a wonderful life, Tommy, but it's over right now," he said.
"I must say this, in the UCLA, they really did a wonderful job. So I'm here."
"[The medical staff said] What do you want to do now? I was in there for a week. And I said, 'I've got to get back on the stage'. This is where I belong. I can't live without this, believe me."
Sir Tom recently made headlines after revealing ITV had "made the decision" to "fire" him from The Voice UK coaching panel, having served as…
Regulatory authorities across Asia are intensifying oversight on pharmaceutical development and production, aiming to enforce stricter quality control and clinical safety. India is introducing immediate operational penalties for factories that fail government quality testing, while China has curbed a popular shortcut for human trials. These policy shifts force regional drugmakers and international partners to navigate far more stringent compliance processes before commercialization.
Physicians seeking alternative therapies when standard statin regimens fail to sufficiently reduce LDL cholesterol have critical comparative data to guide clinical decisions. Amgen's injectable PCSK9 inhibitor proved superior to a generic oral alternative by significantly cutting heart attack rates in patients with clogged coronary arteries. These real-world trial findings clarify the clinical advantages of using advanced targeted therapies over traditional oral absorption inhibitors.
The newly distributed resource fills a vital gap for individuals recovering from severe skin trauma who often struggle with post-hospital grooming and daily self-care routines. By partnering with the Chhanv Foundation, the Pune teenager provides practical advice on non-medicated skincare and sensitive skin maintenance directly to patients in medical centers across India. This initiative aims to restore personal confidence and ease the transition back into everyday routines.